title: Tumor-derived IL-6 may contribute to the immunological defect in CLL.
authors.forename: A G S
authors.initials: AG
authors.lastname: Buggins
authors.forename: P E M
authors.initials: PE
authors.lastname: Patten
authors.forename: J
authors.initials: J
authors.lastname: Richards
authors.forename: N S B
authors.initials: NS
authors.lastname: Thomas
authors.forename: G J
authors.initials: GJ
authors.lastname: Mufti
authors.forename: S
authors.initials: S
authors.lastname: Devereux
mesh_terms: D006801:Humans; D015850:Interleukin-6 / Q000276:immunology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000473:pathology; D009363:Neoplasm Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
chemical_list: D015850:Interleukin-6; D009363:Neoplasm Proteins